Company Info

 

Company Overview

  • Jasper Clinical Research & Development, Inc. is an independent phase I-III clinical CRO. While specializing in innovative early clinical studies, Jasper delivers exceptional speed, flexibility and value to clients with imple biopharmaceutic and pilot clinical studies.
  • Jasper Clinic, Inc. is a 50 bed unit that excels in first in human, cardiac safety, PK/PD, drug interaction and methodology studies, and has proven expertise incorporating pharmacogenetics and biomarkers into studies.
  • Jasper has a proven record of excellence in phase I study conduct in support of project needs throughout clinical development.  Ask to speak to clients that are willing to give you direct input on their experience here - we'll introduce you.
  • Jasper partners easily with other life sciences CROs when needed, regardless of location, to deliver complete, integrated solutions to clinical study needs.
  • Jasper's nursing, medical and scientific staff averages over 15 years of industry experience in a broad range of therapeutic areas.
  • Jasper is located on the campus of Bronson Hospital, and is physically connected to its Level 1 trauma center.
  • Jasper staff provide resource-effective and scientifically sound input into lead assessment, exploratory development, pharmacokinetic analyses and clinical pharmacology R&D planning. Jasper's project managers are experienced providers protocol and study report writing, clinical trial monitoring and study management services.

Recent Successes

  • Designed, conducted and interpreted proof-of-mechanism study
  • Phase IV formulation comparison study
  • Recruited PK/tolerability in glaucoma / ocular hypertension
  • 2 First -Time- in- Human studies completed; 1 extended for biomarker refinement
  • Pilot bioavailability trial for nutritional supplement
  • First-time-in -Human in normals with non-absorbed drug, strict dietary control
  • PK/PD / tolerability CNS study in elderly (65-90)
  • PK/tolerability in type II diabetic subsets (two clients)
  • Biomarker POTV & "Theranostic" methodology study with ethnic subsets
  • Two device studies
  • Smoking study
  • Pivotal QT trial bundled into larger project

Collaborations

  • Innovative Analytics
  • PharmOptima
  • AvTech
  • Bronson Methodist Hospital
  • Southwest Michigan First
  • e-Research Technology
  • Medifacts
  • Biomedical Systems Corporation
  • Advanced Cardiac Healthcare
  • Clinical Logistics Inc
  • Alpine
  • Forensic Fluids Laboratories